Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2024-05-08 to 2025-10-07
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$6.6M
across 2 rounds
CO-INVESTORS
3
named beside it
Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2024-05-08 to 2025-10-07
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Celaid Therapeutics Inc. A biotechnology startup originating from the University of Tokyo and the University of Tsukuba, with proprietary technology for the selective ex vivo expansion of hematopoietic stem cells (HSCs) | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $3.7M | 2025-10-07 | [ PART ] |
Celaid Therapeutics Inc. A biotechnology startup originating from the University of Tokyo and the University of Tsukuba, with proprietary technology for the selective ex vivo expansion of hematopoietic stem cells (HSCs) | Series A ext. Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $3.0M | 2024-05-08 | [ PART ] |